6.35

3.79% -0.25

Bioventus Inc (BVS)

Overview News Price History Option Chain Financials Discussions Forecast

Bioventus Inc stock is traded at $6.35, with a volume of 258.98K. It is down -3.79% in the last 24 hours and down -6.48% over the past month. Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

Previous Close:

$6.60

Open:

$6.55

24h Volume:

258.98K

Relative Volume:

0.69

Market Cap:

$455.21M

Revenue:

$555.06M

Net Income/Loss:

$-39.48M

P/E Ratio:

-10.58

EPS:

-0.6

Net Cash Flow:

$29.05M

1W Performance:

-7.43%

1M Performance:

-6.48%

6M Performance:

-43.05%

1Y Performance:

+6.90%

1-Day Range:

$6.33

$6.60

1-Week Range:

$6.33

$7.08

52-Week Range:

$5.28

$14.38

Bioventus Inc Stock (BVS) Company Profile

Name

Bioventus Inc

Sector

Healthcare (1172)

Industry

Medical Devices (150)

Phone

(919) 474-6700

Address

4721 EMPEROR BOULEVARD, SUITE 100, DURHAM

Employee

930

Twitter

Next Earnings Date

2025-03-11

Latest SEC Filings

BVS's Discussions on Twitter

Compare BVS with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BVS Bioventus Inc	6.35	455.21M	555.06M	-39.48M	29.05M	-0.60
ABT Abbott Laboratories	132.28	233.36B	42.34B	13.50B	6.66B	7.71
SYK Stryker Corp	373.37	147.15B	23.22B	2.86B	3.58B	7.40
BSX Boston Scientific Corp	101.73	146.97B	17.55B	2.03B	2.72B	1.37
MDT Medtronic Plc	86.17	112.76B	33.54B	4.66B	5.19B	3.62
EW Edwards Lifesciences Corp	73.27	44.46B	5.54B	4.18B	623.10M	7.00

Bioventus Inc Stock (BVS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-17-24	Upgrade	JP Morgan	Underweight → Neutral
Dec-07-23	Upgrade	Canaccord Genuity	Hold → Buy
Aug-09-23	Upgrade	Craig Hallum	Hold → Buy
Nov-22-22	Downgrade	Craig Hallum	Buy → Hold
Nov-09-22	Downgrade	Canaccord Genuity	Buy → Hold
Nov-09-22	Downgrade	JP Morgan	Overweight → Underweight
Mar-15-22	Initiated	Craig Hallum	Buy
Nov-15-21	Resumed	Morgan Stanley	Overweight
Nov-10-21	Resumed	JP Morgan	Overweight
Jul-01-21	Downgrade	Goldman	Buy → Neutral
Mar-08-21	Initiated	Canaccord Genuity	Buy
Mar-08-21	Initiated	Goldman	Buy
Mar-08-21	Initiated	JP Morgan	Overweight
Mar-08-21	Initiated	Morgan Stanley	Overweight

View All

Bioventus Inc Stock (BVS) Latest News

Jun 14, 2025

Do Options Traders Know Something About Bioventus Stock We Don't? - The Globe and Mail

Jun 14, 2025

Jun 06, 2025

(BVS) Proactive Strategies - news.stocktradersdaily.com

Jun 06, 2025

Bone Growth Stimulator Market Booming Worldwide with - openPR.com

Jun 06, 2025

Jun 04, 2025

bioventus inc. reports results of annual stockholders meeting By Investing.com - Investing.com South Africa

Jun 04, 2025

bioventus inc. reports results of annual stockholders meeting - Investing.com

Jun 04, 2025

Bioventus Holds Annual Meeting, Elects Directors - TipRanks

Jun 04, 2025

Jun 02, 2025

Cetera Investment Advisers Sells 1,805 Shares of Bioventus Inc. (NYSE:BVS) - Defense World

Jun 02, 2025

May 30, 2025

Bioventus’ Cut Losses 46%, Organic Sales Up 5% - Orthopedics This Week

May 30, 2025

Millennium Management LLC Sells 60,811 Shares of Bioventus Inc. (NYSE:BVS) - Defense World

May 30, 2025

May 26, 2025

Janus Henderson Group PLC Acquires Shares of 17,200 Bioventus Inc. (NYSE:BVS) - Defense World

May 26, 2025

May 19, 2025

Balyasny Asset Management L.P. Invests $133,000 in Bioventus Inc. (NYSE:BVS) - Defense World

May 19, 2025

BNP Paribas Financial Markets Invests $1.66 Million in Bioventus Inc. (NYSE:BVS) - Defense World

May 19, 2025

May 18, 2025

Price T Rowe Associates Inc. MD Has $160,000 Stock Holdings in Bioventus Inc. (NYSE:BVS) - Defense World

May 18, 2025

May 16, 2025

Bioventus (BVS) Price Target Trimmed by Craig-Hallum Analyst | BVS Stock News - GuruFocus

May 07, 2025

Bioventus Inc. (NASDAQ:BVS) Q1 2025 Earnings Call Transcript - Insider Monkey

May 07, 2025

Is Bioventus (NASDAQ:BVS) Using Too Much Debt? - simplywall.st

May 07, 2025

Bioventus First Quarter 2025 Earnings: EPS Beats Expectations - Yahoo Finance

May 07, 2025